Related Experiment Video
Updated: Oct 9, 2025

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020
Measuring hypertrophy in neonatal rat primary cardiomyocytes and human iPSC-derived cardiomyocytes
Kyla Bourque1, Cara Hawey1, Jace Jones-Tabah1
1Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec H3G 1Y6, Canada.
Insights
Cardiac hypertrophy, a thickening of the heart wall, can impair blood flow. This study reviews models for studying cardiac hypertrophy, including cell lines and stem cell-derived cardiomyocytes.
Area of Science:
- Cardiology
- Molecular Biology
- Stem Cell Research
Background:
- Left ventricular hypertrophy is an adaptive response to increased cardiac workload, often seen in hypertension and coronary artery disease.
- Cardiac hypertrophy can lead to myocardial stiffening, impairing systemic blood supply.
- Understanding the molecular mechanisms of cardiac hypertrophy is crucial for developing therapeutic strategies.
Purpose of the Study:
- To review existing in vitro and in vivo model systems used for studying cardiac hypertrophy.
- To provide detailed methodologies for isolating primary neonatal rat cardiomyocytes and generating human induced pluripotent stem cell-derived cardiomyocytes.
- To describe methods for modeling cardiac hypertrophy in vitro using advanced imaging and molecular analysis.
Main Methods:
- Review of established in vitro (cell lines, iPSC-CMs) and in vivo (rodent, large animal) models.
- Detailed protocols for primary neonatal rat cardiomyocyte isolation.
- Generation of cardiomyocytes from human induced pluripotent stem cells (hiPSC-CMs).
- In vitro modeling of hypertrophy using gene expression analysis, immunofluorescence, and high-content imaging.
Main Results:
- Various model systems, including cell lines, animal models, and iPSC-CMs, have been instrumental in understanding cardiac hypertrophy.
- Primary neonatal rat cardiomyocytes and hiPSC-CMs offer valuable platforms for mechanistic studies.
- Integrated approaches combining molecular and imaging techniques enable robust in vitro hypertrophy modeling.
Conclusions:
- A range of experimental models are available for investigating the molecular drivers of cardiac hypertrophy.
- Human iPSC-derived cardiomyocytes provide a disease-relevant model for studying hypertrophic cardiomyopathies.
- Standardized methods for cardiomyocyte isolation and in vitro hypertrophy modeling are essential for advancing research in this field.
Abstract:
In the heart, left ventricular hypertrophy is initially an adaptive mechanism that increases wall thickness to preserve normal cardiac output and function in the face of coronary artery disease or hypertension. Cardiac hypertrophy develops in response to pressure and volume overload but can also be seen in inherited cardiomyopathies. As the wall thickens, it becomes stiffer impairing the distribution of oxygenated blood to the rest of the body. With complex cellular signalling and transcriptional networks involved in the establishment of the hypertrophic state, several model systems have been developed to better understand the molecular drivers of disease. Immortalized cardiomyocyte cell lines, primary rodent and larger animal models have all helped understand the pathological mechanisms underlying cardiac hypertrophy. Induced pluripotent stem cell-derived cardiomyocytes are also used and have the additional benefit of providing access to human samples with direct disease relevance as when generated from patients suffering from hypertrophic cardiomyopathies. Here, we briefly review in vitro and in vivo model systems that have been used to model hypertrophy and provide detailed methods to isolate primary neonatal rat cardiomyocytes as well as to generate cardiomyocytes from human iPSCs. We also describe how to model hypertrophy in a "dish" using gene expression analysis and immunofluorescence combined with automated high-content imaging.
More Related Videos
06:42Author Spotlight: Real-Time Measurements of Calcium and Contractility Parameters in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: May 26, 2023
13:13High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
Published on: September 23, 2014